Inhibition of adipose conversion of 3T3 fibroblasts by tumour promoters.
about
Identification and assessment of tumor-oromoting and cocarcinogenic agents: state-of-the-art in vitro methodsInterferon-induced differentiation of U937 cells. Comparison with other agents that promote differentiation of human myeloid or monocytelike cell linesRegulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotionAdipocyte differentiation selectively represses the serum inducibility of c-jun and junB by reversible transcription-dependent mechanisms.Alterations in polyamine levels induced by phorbol diesters and other agents that promote differentiation in human promyelocytic leukemia cells.Metaplastic change in mesenchymal stem cells induced by activated ras oncogeneTransforming growth factor beta1 induces differentiation in human papillomavirus-positive keratinocytes.Coupling of proadipocyte growth arrest and differentiation. II. A cell cycle model for the physiological control of cell proliferationCoupling of proadipocyte growth arrest and differentiation. I. Induction by heparinized medium containing human plasmaRegulation of the terminal event in cellular differentiation: biological mechanisms of the loss of proliferative potentialA growth factor-repressible gene associated with protein kinase C-mediated inhibition of adipocyte differentiationLoss of proliferative potential during terminal differentiation coincides with the decreased abundance of a subset of heterogeneous ribonuclear proteins.Coupling of growth arrest and differentiation at a distinct state in the G1 phase of the cell cycle: GD.Control of differentiation of a mammary cell line by lipids.Phorbol esters induce differentiation in human malignant T lymphoblasts.Tumor promoters enhance myeloid and erythroid colony formation by normal mouse hemopoietic cells.Selective effects of phorbol 12-myristate 13-acetate on myofibrils and 10-nm filaments.Inhibition of simian virus 40 T-antigen expression by cellular differentiation.Tumor promoter 12-O-tetradecanoylphorbol 13-acetate stimulates simian virus 40 induction by DNA-damaging agents and tumor initiatorsAntagonism between epidermal growth factor and phorbol ester tumor promoters in human breast cancer cells.Tumor promoter phorbol myristic acetate stimulates immunoglobulin secretion correlated with growth cessation in human B lymphocyte cell lines.Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents.Tumor promoter-mediated inhibition of cell differentiation: suppression of the expression of erythroid functions in murine erythroleukemia cells.Effect of tumor promoters, protease inhibitors, and repair processes on x-ray-induced sister chromatid exchanges in mouse cells.Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester.Phorbol ester inhibits furosemide-sensitive potassium transport in BALB/c 3T3 preadipose cells.Catabolism of 2-deoxyglucose by phagocytic leukocytes in the presence of 12-O-tetradecanoyl phorbol-13-acetate.Opposing effects of interferon produced in bacteria and of tumor promoters on myogenesis in human myoblast culturesAn initiator of carcinogenesis selectively and stably inhibits stem cell differentiation: a concept that initiation of carcinogenesis involves multiple phases.A tumor-promoting phorbol ester inhibits the cyclic AMP response of rat embryo fibroblasts to catecholamines and prostaglandin E1.In vitro studies on the mode of action of the phorbol esters, potent tumor promoters: part 1.In vitro studies on the mode of action of the phorbol esters, potent tumor promoters, part 2.Epidermal growth factor, like phorbol esters, induces plasminogen activator in HeLa cells.Differentiation modulates the balance of positive and negative Jun/AP-1 DNA binding activities to regulate cellular proliferative potential: different effects in nontransformed and transformed cells.Multiparameter flow cytometric analysis of the effects of indomethacin on adipocyte differentiation in A31T6 cells.Cell cycle models for the aberrant coupling of growth arrest and differentiation in hyperplasia, metaplasia, and neoplasia.Aproliferin--a human plasma protein that induces the irreversible loss of proliferative potential associated with terminal differentiationRegulation of differentiation and protein kinase C expression in 3T3 T proadipocytes: effects of TGF-beta and transformation.Down-regulation of platelet-derived growth factor receptor expression during terminal differentiation of 3T3-L1 pre-adipocyte fibroblasts.Inhibition of distinct steps in the adipocyte differentiation pathway in 3T3 T mesenchymal stem cells by dimethyl sulphoxide (DMSO).
P2860
Q23914589-F1781F15-92D6-4C67-9127-7B2C6ED65C8FQ33821852-64F69E00-7ECE-4003-99D8-950257B77987Q34037444-6C5A6E39-6ADE-4905-B745-A7DFFF12579EQ35259404-17043221-F2BB-4F3E-8E1E-8A27EED4BFA5Q35423342-7A4342F7-A239-4458-A01D-7C176FB573D5Q35811937-62CCC871-090D-4D1F-8127-B9B6091C404CQ35866322-97E39663-0AC8-4D47-970E-ABA8E6C9D94AQ36209105-30D6FA1A-4687-4CA4-A99F-533038C472A6Q36209124-5A1178CE-E3E0-45EC-82F7-A1B1D75854E6Q36214933-EB5C80D0-FE71-413B-A837-F280251D5393Q36219130-0CDB3AE1-4BCC-4C44-B80A-7716E30E8730Q36221750-5AFF7417-8033-4642-BDD3-2C62FE7182D6Q36280462-114591E8-3D11-4116-88B9-055352766440Q36360457-218DB994-558D-4CCF-98A9-D4E935392CE6Q36390772-D94F4FEB-EBCA-4575-A8FE-6AB65BB0B8D8Q36398238-7AF28FAF-036C-4558-AD18-A5C0BC938BEFQ36405782-CDE5B33C-72ED-4DB7-B72E-33087CADECA1Q36828441-3C6C6859-6C09-4B38-9EBA-23C46485D9BCQ36938669-01DE74B4-8192-4936-AC2D-DFEB1737EABEQ36997119-F17B4152-5A6E-4295-996F-400A4040AEA1Q37004437-5AF69350-A09B-4185-A96F-4CC199646E1EQ37320906-8833F222-40C1-4A67-A0D5-C695A47DF7DDQ37328079-128FE763-F507-4735-A480-B28FD4CD0301Q37328304-6DDC5E83-5AE6-46E5-B6E1-200E37084C67Q37333253-26FFC55E-126B-4888-A40E-6D013FF52E40Q37342334-A3414388-7339-41BA-8F64-47793C8D75ADQ37594132-31D7F315-93C4-4EE9-84B4-D70FC6595BB8Q37611930-F9724FC2-4434-4B39-846D-EF6D93244C69Q37686889-DA45CE97-E3B8-407A-AC70-EA83232183D3Q40244904-45FFF0CA-6F0B-411C-9703-2A0E67D111B1Q40294656-B646D613-1CFB-4598-8945-DFF516EEC43BQ40309436-10F7DC32-8C0A-4765-B404-D5FC7DB84968Q40683702-65AA7593-ABAA-4ED9-8925-D81F627D9C31Q41154300-340827B0-CB7C-409E-953A-2F7153E49F99Q41568729-5CD65CFB-4300-4685-9DE7-082F0BB0D4B0Q42577665-50F5A7F2-87D2-48BE-A247-DD4F3AA2AC16Q42752124-B225E17A-BFD9-4647-AF67-AA95EDA35662Q42800943-2AE7B9FA-759C-4FDD-841A-55D76DADB8B3Q42812177-566B1251-BB0C-4D34-BDA7-A05220E7335FQ42812929-57C4F7A1-9393-4ECF-9817-24FD29D4E896
P2860
Inhibition of adipose conversion of 3T3 fibroblasts by tumour promoters.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
1977年论文
@zh
1977年论文
@zh-cn
name
Inhibition of adipose conversion of 3T3 fibroblasts by tumour promoters.
@en
Inhibition of adipose conversion of 3T3 fibroblasts by tumour promoters.
@nl
type
label
Inhibition of adipose conversion of 3T3 fibroblasts by tumour promoters.
@en
Inhibition of adipose conversion of 3T3 fibroblasts by tumour promoters.
@nl
prefLabel
Inhibition of adipose conversion of 3T3 fibroblasts by tumour promoters.
@en
Inhibition of adipose conversion of 3T3 fibroblasts by tumour promoters.
@nl
P2093
P356
P1433
P1476
Inhibition of adipose conversion of 3T3 fibroblasts by tumour promoters.
@en
P2093
P2888
P304
P356
10.1038/269247A0
P407
P577
1977-09-01T00:00:00Z
P6179
1008566875